Altria Group, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Altria Group files Amendment No. 1 to its 2025 10-K to incorporate Anheuser-Busch InBev's financial statements.
NYSE
Altria Group, Inc. reported a significant decline in reported net earnings for 2025 due to substantial e-vapor segment impairments, despite growth in adjusted diluted EPS and progress in its smoke-free portfolio.
NYSE
Altria Group, Inc. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to incorporate the consolidated financial statements of its foreign equity investee, Anheuser-Busch InBev SA/NV, as required by SEC regulations.
NYSE
Altria's 2024 10-K filing highlights its strategic shift towards smoke-free products while addressing regulatory hurdles and evolving consumer preferences in the tobacco industry.
NYSE
Altria Group has filed an amendment to its annual report to include the financial statements of its equity investee, Anheuser-Busch InBev, for the years 2021-2023.
NYSE
Altria Group, Inc. releases its annual 10-K report, outlining its financial performance, strategic initiatives, and risk factors for the fiscal year ended December 31, 2023.